Mm. Kesavulu et al., Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications, DIABETE MET, 26(5), 2000, pp. 387-392
Serum levels of total cholesterol, triglycerides, lipoproteins, lipid perox
ides (TBARS) and erythrocyte antioxidant enzyme activities were measured in
105 non insulin dependent diabetic patients, among whom 38 had microvascul
ar complications (MVC) of diabetes. All the diabetic patients had higher co
ncentrations of glycated hemoglobin (HbA1) compared to controls (10.51+/-2.
42% vs 6.31+/-0.85% P<0.001). Significant increase of serum triglycerides (
TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) an
d very low density lipoprotein cholesterol (VLDL-C) and a significant decre
ase of high density lipoprotein cholesterol (HDL-C) were observed in the di
abetic patients compared to controls (TG: 2.31 +/- 0.9 mmol/l vs 1.53 +/- 0
.48 mmol/l P < 0.001; TC: 5.94 +/- 1.4 mmol/l vs 4.3 +/- 0.85 mmol/l P < 0.
001; LD L-C: 3.96 +/- 1.33 mmol/l vs 2.39 +/- 0.8 mmol/l P < 0.001; VLDL-C:
0.46 +/- 0.2 mmol/l vs 0.3 +/- 0.09 mmol/l P<0.001; HDL-C: 0.81 +/- 0.24 m
mol/l vs 1.04 +/- 0.18 mmol/l P < 0.001). Significantly increased levels of
serum TEARS were observed in diabetic patients compared to those in contro
ls (TBARS: 6.7 +/- 1.5 mmol/l vs 5.14 +/- 0.61 mmol/l P < 0.001). Erythrocy
te catalase (CAT) activity was increased and Glutathione peroxidase (GPx) a
ctivity was decreased in diabetic patients compared to controls, but no sig
nificant change in Superoxide dismutase (SOD) activity was observed in dia
betic patients (CAT: 104.94 +/- 37.1 KU/g Hb vs 85.8 +/- 23.6 KU/g Hb, P <
0.01; GPx: 30 +/- 9.7 U/g Hb/min vs 40.84 +/- 12.3 U/g Hb/min, P < 0.001; S
OD: 2.4 +/- 1.2 U/mg Hb/min vs 2.55 +/- 0.84 U/mg Hb/min, P=NS). in compari
son with the diabetic group without MVC, the diabetic group with MVC had de
creased GPx and SOD activities, while no difference was observed between th
ese two groups regarding CAT activity (GPx: 25.32 +/- 8.4 U/g Hb/min vs 34.
5 +/- 8.8 U/g Hb/min, P < 0.001; SOD: 1.83 +/- 0.53 U/mg Hb/min vs 2.84 +/-
1.4 U/mg Hb/min, P<0.001; CAT: 106.3 +/- 39.9 KU/g Hb vs 103 +/- 34.9 KU/g
Hb, P = NS). TEARS concentrations were significantly increased in the grou
p with MVC compared to the group without these complications, indicating a
positive relationship between TEARS and MVC of diabetes (7.05 +/- 1.23 mmol
/l vs 6.3 +/- 1.02 mmol/l, P < 0.001). Serum triglycerides, LDI. and VLDL c
holesterol concentration were significantly higher in diabetics with MVC th
an in diabetics without the complications (TG: 2.7 +/- 0.98 mmol/l vs 2.13
+/- 0.82 mmol/l, P < 0.01; LDL - C: 4.45 +/- 1.3 mmol/l vs 3.67 +/- 1.3 mmo
l/l, P < 0.02; VLDL-C: 0.53 +/- 0.19 mmol/l vs 0.43 +/- 0.16 mmol/l, P < 0.
01), and the serum levels of TC in the group with MVC showed a positive cor
relation with their lipid peroxide levels (r= 0.368, P < 0.001). The increa
se in TEARS and the decreased GPx and SOD activities in diabetics with MVC
in this study indicate that these factors may contribute to the occurrence
of micro vascular complications in NIDDM patients.